From: Immune response to allogeneic equine mesenchymal stromal cells
 |  | Autologous | Blood donor | MHC II-high | MHC II-low |
---|---|---|---|---|---|
CD59 Day 3 | 1:1 | 3.53 (0.69)a | 4.24 (3.08)a | 5.42 (2.69)a,b | 14.5 (10.4)b |
Control | 3.68 (0.98) | 4.55 (4.52) | 7.75 (7.03) | 2.31 (1.08) | |
CD59 Day 5 | 1:1 | 9.54 (27.5) | 11.5 (10.1) | 5.18 (7.53) | 9.08 (4.61) |
Control | 4.41 (0.77) | 2.60 (1.90) | 4.74 (2.69) | 4.01 (2.08) | |
FGF-2 Day 3 | 1:1 | 852 (21.8)a,c | 5910 (5300)b | 450 (112)a | 2470(2150)b,c |
Control | 919 (192) | 5100 (3690) | 955 (1110) | 4150 (5550) | |
FGF-2 Day 5 | 1:1 | 1450 (307)a | 1390 (1260)a | 473 (397)b | 1100 (451)a,c |
Control | 1100 (1040) | 3570 (3590) | 1820 (1520) | 2850 (6170) | |
HGF Day 3 | 1:1 | 41.2 (3.55)a | 307 (137)b | 76.4 (64.4)c | 386 (184)b |
Control | 166 (43.4) | 263 (391) | 136 (48.9) | 572 (440) | |
HGF Day 5 | 1:1 | 85.8 (17.5) | 132 (55.0) | 113 (52.3) | 119 (14.9) |
Control | 189 (80.5) | 296 (236) | 356 (172) | 1050 (519) | |
IDO Day 3 | 1:1 | 123 (26.8)a | 3850 (1220)b | 207 (154)a | 3510 (2170)b |
Control | 3.90 (1.41) | 8.01 (5.27) | 45.7 (51.1) | 9.90 (11.3) | |
IDO Day 5 | 1:1 | 485 (222)a | 1420 (1100)b | 205 (225)a | 2050 (1900)b |
Control | 2.16 (1.42) | 4.55 (8.86) | 5.08 (4.62) | 3.29 (2.22) | |
IL-10 Day 3 | 1:1 | 17.0 (1.45)a | 57.1 (88.4)b | 32.0 (7.3)a | 66.4 (45.5)b |
Control | 1.71 (1.45) | 4.32 (1.55) | 16.5 (12.9) | 24.7 (22.1) | |
IL-10 Day 5 | 1:1 | 29.7 (13.5) | 258 (214) | 62.4 (17.6) | 207 (230) |
Control | 5.83 (2.50) | 6.71 (3.10) | 5.74 (4.76) | 7.15 (4.08) | |
IL-ra Day 3 | 1:1 | 27.0 (3.0)a,b | 76.0 (353)b,c | 24.4 (14.5)a | 725 (500)c |
Control | 2.0 (6.5) | 5.7 (3.9) | 14.9 (39.3) | 18.5 (21.2) | |
IL-ra Day 5 | 1:1 | 78.4 (33.6)a,b | 65.6 (39.2)a,b | 29.6 (14.6)a | 106 (53.9)b |
Control | 3.2 (2.1) | 6.4 (2.3) | 5.1 (7.9) | 3.2 (2.6) | |
IL-2 Day 3 | 1:1 | 4.7 (0.4)a | 25.5 (12.3)a,b | 10.7 (15.9)a | 38.4 (11.6)b |
Control | 2.3 (0.5) | 3.3 (1.1) | 7.8 (1.6) | 5.9 (1.3) | |
IL-2 Day 5 | 1:1 | 4.6 (5.2) | 11.3 (9.2) | 18.5 (4.7) | 11.9 (5.6) |
Control | 2.2 (0.7) | 2.5 (3.0) | 1.9 (1.4) | 6.0 (4.5) | |
Sox2 Day 3 | 1:1 | 1.0 (0.1)a,c | 3.6 (2.9)b | 1.0 (0)c | 2.5 (2.7)a,b |
Control | 1.0 (0.2) | 1.2 (0.3) | 3.7 (10.6) | 1.1 (0.2) | |
Sox2 Day 5 | 1:1 | 5.7 (9.7)a,b | 1.0 (0.6)a,b | 1.9 (2.4)a | 1.0 (0)b |
Control | 1.0 (0) | 1.0 (0) | 1.0 (0) | 1.0 (0) | |
TGFB1 Day 3 | 1:1 | 299 (20)a | 625 (86)b | 334 (89)a | 556 (294)b |
Control | 422 (71) | 255 (54) | 283 (112) | 249 (46) | |
TGFB1 Day 5 | 1:1 | 411 (101) | 601 (320) | 460 (213) | 669 (384) |
Control | 575 (38) | 428 (47) | 573 (174) | 409 (36) | |
VEGF Day 3 | 1:1 | 19,900 (500) | 20,700 (19,700) | 26,100 (6600) | 21,600 (4460) |
Control | 2880 (550) | 6030 (3380) | 3200 (4900) | 8170 (7780) | |
VEGF Day 5 | 1:1 | 18,200 (4600) | 18,100 (14,600) | 23,000 (6800) | 14,900 (3570) |
Control | 4130 (406) | 4410 (1650) | 5520 (780) | 3930 (5490) |